ReviewEmerging infectious diseases
New technologies to prevent intravascular catheter-related bloodstream infections.
Review in Emerging infectious diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.
- Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.The Cochrane database of systematic reviews · 2016Pooled it
- Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients.Intensive care medicine · 2004Trial
- Effect of silver nanocoatings on catheters for haemodialysis in terms of cell viability, proliferation, morphology and antibacterial activity.Journal of materials science. Materials in medicine · 2013Article
- Antimicrobial impregnated catheters in the prevention of catheter-related bloodstream infection in hospitalized patients.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2007Article
- Clinical review: new technologies for prevention of intravascular catheter-related infections.Critical care (London, England) · 2004Review
- Candida infections of medical devices.Clinical microbiology reviews · 2004Review
- Nosocomial Infections in the Intensive Care Unit Associated with Invasive Medical Devices.Current infectious disease reports · 2001Article
- The Role of Intravascular Devices in Sepsis.Current infectious disease reports · 2001Article
- Nosocomial infections in pediatric intensive care units.Indian journal of pediatrics · 2001Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Most intravascular catheter-related infections are associated with central venous catheters. Technologic advances shown to reduce the risk for these infections include a catheter hub containing an iodinated alcohol solution, short-term chlorhexidine-silver sulfadiazine- impregnated catheters, minocycline-rifampin-impregnated catheters, and chlorhexidine- impregnated sponge dressings. Nontechnologic strategies for reducing risk include maximal barrier precautions during catheter insertion, specialized nursing teams, continuing quality improvement programs, and tunneling of short-term internal jugular catheters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.